IP Verse

James Poole competitive analysis

Explore patent oppositions filed by James Poole against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Mar 12, 2026

Patent Number	Title	Applicant	Opposition Date
EP3965111	Methods And Systems For Genomic Analysis	PERSONALIS	Jan 29, 2026
EP4013316	Implantable Embolization Device	COVIDIEN LP	Jan 16, 2026
EP3867372	Methods For Targeted Insertion Of Dna In Genes	BLUEALLELE	Jan 2, 2026
EP4071250	Combinatorial Dna Screening	MYRIAD WOMENS HEALTH	Dec 4, 2025
EP4284774	Novel Synthesis Of Salcaprozic Acid By Amide Formation	NOVO NORDISK	Oct 28, 2025
EP3587587	Compositions And Methods For Quantifying A Nucleic Acid Sequence In A Sample	ENVIROLOGIX	Aug 6, 2025
EP3594239	Methods For Improving Safety Of Blood-Brain Barrier Transport	F HOFFMANN LA ROCHE	Jul 16, 2025
EP3102612	Proteomic Sample Preparation Using Paramagnetic Beads	EUROPEAN MOLECULAR BIOLOGY LABORATORY	Jul 9, 2025
EP3601367	"Chimeric Molecules And Uses Thereof"	THE UNIVERSITY OF QUEENSLAND	May 14, 2025
EP4209499	Charged Depth Filtration Of Antigen-Binding Proteins	AMGEN	May 2, 2025

Discover the latest PTAB cases involving James Poole, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing James Poole with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Mar 12, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
JAMES POOLE	158	-	-	-
AMGEN	8	138	8	11
MASSACHUSETTS INSTITUTE OF TECHNOLOGY	-	77	-	16
PRESIDENT AND FELLOWS OF HARVARD COLLEGE	-	90	-	8